Dr. Daniel (Yingxu) Peng is a Senior CMC Reviewer and QbD Liaison in Division of Chemistry 1, Office of Generic Drugs (OGD). Prior to joining OGD, Dr. Peng worked as a Senior Formulation Scientist/Project Lead in late stage Product Development department of AstraZeneca (Wilmington, DE) for 4 years. Dr. Peng obtained his Ph.D. in Pharmaceutics from West China University of Medical Sciences (Chengdu, China) in 1998. He completed two years post-doctoral research at College of Pharmacy, University of Tennessee Health Science Center (UTHSC, Memphis, TN). He then served as faculty in UTHSC for 4 years where he mentored Ph.D. students, supervised post-doctoral fellows, co-designed and implemented the "Hands-on Tablet Technology Course". He has published 3 book chapters, 16 peer reviewed papers and 4 US patent applications. Dr. Peng has extensive experience in formulation and process development for solid dosage forms. He is also skilled in applying Design of Experiments (DOE), Multivariate analysis (MVA) and Artificial Neural Network (ANN) software for pharmaceutical product development.